Alzheimer's Disease Flashcards

1
Q

AD is the most common cause of ___?

A

Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What are 2 molecular characterizations of AD?

A
  1. Amyloid-beta plaques
  2. Neurofibrillary tangles (NFTs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Describe amyloid-beta plaques.

A

Clumps of AB peptides (toxic fragments derived from the Amyloid Precursor Protein [APP])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Describe neurofibrillary tangles (NFTs).

A
  • Clusters of hyperphosphorylated (excessive phosphorylation or lots of phosphate groups) tau proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What is the function of tau proteins?

A

Stabilize the cell’s transport structures (microtubules)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What is a peptide?

A
  • A short chain of amino acids
  • Can act as signaling molecules, hormones, or byproducts of protein processing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What is APP and its relation to AD?

A
  • Amyloid Precursor Protein
  • Transmembrane protein mostly found in neurons
  • Helps out with cell growth and synaptic health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Explain the normal processing pathway of APP.

A

Non-amyloidogenic pathway
- alpha-secretase cleaves APP and splits it in 2
- This prevents the formation of AB peptides and produces soluble APP-alpha
- No harmful peptides are formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What does it mean when a protein is cleaved?

A

An enzyme cuts a protein or peptide at a specific site to turn the protein on or off or produce fragments with different functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Explain the abnormal processing pathway of APP.

A

Amyloidogenic pathway
- beta-secretase cleaves APP at a different site
- C99 is produced (new fragment)
- gamma-secretase cleaves C99 to release AB peptides into the extracellular space
- AB peptides (think of AB42) aggregate into plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What do AB plaques look like?

A
  • Dense, spherical deposits in the brain tissue
  • Central core of aggregated AB, surrounded by a halo of damaged neurons and glial cells (astrocytes and microglia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Define 3 causes of AD formation.

A
  1. APP metabolism shifts
  2. Tau protein dysfunction
  3. Age-related factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

An increased activity of ____ and ____ in neurons would lead to excessive AB production.

A

beta-secretase, gamma-secretase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

How does AB accumulations affect tau proteins?

A
  • Triggers tau hyperphosphorylation
  • Tau loses ability to stabilize microtubules and form tangles inside neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

How does age affect AB clearance?

A
  • The older we get, the harder it is for our brains to clear AB peptides
  • Inflammation and oxidative stress increases (more protein aggregation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Describe the early stages of AD.

A
  • AB peptides begin to cluster, forming oligomers (toxic to synapses)
  • May occur years before symptoms appear
1
Q

Describe the intermediate stages of AD.

A
  • Larger AB plaques form
  • Immune cells (microglia) are activated and release inflammatory molecules that damage neurons
  • Tau tangles spread through the brain (inhibits intracellular transport and cause more neuronal loss)
1
Q

Describe the late stages of AD.

A
  • Widespread neuronal death
  • Brain shrinkage
  • Severe memory loss, disorientation, and motor impairment
1
Q

List cognitive symptoms of AD.

A
  • Progressive memory loss
  • Difficulty solving problems
  • Confusion
1
Q

List behavioral symptoms of AD.

A
  • Mood swings
  • Depression
  • Aggression
1
Q

List physical symptoms of AD.

A
  • Loss of coordination
  • Incontinence
  • Difficult swallowing
1
Q

Describe current treatment for AD.

A
  1. Cholinesterase inhibitors
    - Boost ACh (a NT involved with learning and memory)
  2. NMDA receptor antagonists
    - Reduce damage caused by excessive glutamate (a NT)
1
Q

Describe experimental therapies for AD.

A
  1. Drugs targeting AB plaques
    - Aim to reduce AB production or enhance its clearance
  2. Drugs targeting tau tangles
    - Focus on blocking tau aggregation or reducing its phosphorylation
2
Q

What are some lifestyle interventions that could promote brain health and reduce AB accumulation?

A

Physical exercise and mental stimulation